Table 1.
TBE patients (n = 20) | Control persons (n = 32) | |
---|---|---|
Median age, years (range) | 52.5 (34–88) | 30 (18–57) |
Male gender | 11 (55%) | 20 (62.5%) |
Concomitant diseases* | 9/20 (45%) | – |
Number of CSF samples | 44 | 32 |
Number of serum samples | 44 | 32 |
*11/20 patients were previously completely healthy. Of the 9 patients with concomitant diseases, 2/9 had substitution treatment for hypothyroid, 2/9 were treated for hypertonia, 2/9 had treatment for depression and/or bipolar disease, 6/9 had musculoskeletal pain, 1/9 was operated for mammalian cancer, 1/9 was operated for colon cancer, 1/9 was treated with estrogen substitution, and 1/9 had chronic obstructive lung disease. Neither of the patients were on immunosuppressive treatment